Erythrocyte development

pathway activity — cross-omics
GO:0048821Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Erythrocyte development pathway is significantly associated with the protein abundance of multiple proteins, with the OV cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are CACNA2D1, ELMO1, and RPL5, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Erythrocyte development activity versus CACNA2D1 in OV (Pearson r = 0.17).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
OVCACNA2D1 →+0.629+0.049<.001<.00136
OVELMO1 →+0.407+0.062.002<.00135
OVRPL5 →-0.195-0.043.002.00135
COADDCN →+0.785+0.038<.001.00235
COADENPP1 →+0.560+0.037.001<.00135
GBMEPB41L2 →+0.515+0.056<.001<.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0048821 vs CACNA2D1 — OV

Per-sample scatter of Erythrocyte development activity vs CACNA2D1 in OV.

Explore this scatter interactively →

Exploration